https://www.selleckchem.com/pr....oducts/epalrestat.ht
There is a lack of quality literature describing third-party reimbursement models for pharmacist-led preventive health services, which hinders the ability to implement a standardized model. High quality studies evaluating the cost of reimbursing pharmacist-led cardiovascular preventive health services compared to the savings to the third-party payer should be performed to inform the standardization of payment models. There is a lack of quality literature describing third-party reimbursement models for pharmacist-led preventive health
Like
Comment
Share
